Equities

Panacea Biotec Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
PANACEABIO:NSI

Panacea Biotec Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)326.40
  • Today's Change-1.70 / -0.52%
  • Shares traded122.32k
  • 1 Year change+9.90%
  • Beta0.8357
Data delayed at least 15 minutes, as of Mar 02 2026 09:59 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2025202520242023
ASSETS
Cash And Short Term Investments1,4621,5142,075
Total Receivables, Net1,3841,1141,096
Total Inventory2,2061,8272,056
Prepaid expenses716152
Other current assets, total330336404
Total current assets5,4524,8525,683
Property, plant & equipment, net6,3696,3486,163
Goodwill, net------
Intangibles, net423360259
Long term investments1591281.74
Note receivable - long term434690555
Other long term assets312012
Total assets12,89712,40712,712
LIABILITIES
Accounts payable2,2581,5371,773
Accrued expenses115102110
Notes payable/short-term debt000
Current portion long-term debt/capital leases000.55
Other current liabilities, total1,2981,4501,435
Total current liabilities3,6703,0883,318
Total long term debt222210202
Total debt222210202
Deferred income tax233225204
Minority interest(42)(38)(35)
Other liabilities, total466501587
Total liabilities4,5503,9864,276
SHAREHOLDERS EQUITY
Common stock616161
Additional paid-in capital919919919
Retained earnings (accumulated deficit)7,2987,3837,398
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total695758
Total equity8,3488,4208,436
Total liabilities & shareholders' equity12,89712,40712,712
Total common shares outstanding616161
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.